MorphoSys AG (MOR) Year-over-year earnings per share growth for the last twelve months
Patent protection and the support of a Swiss behemoth have created a formidable technological barrier for competitors. MorphoSys AG (MOR) generates revenue by supplying antibodies to global oncology centers, capturing a massive immunotherapy market. The integration of these developments into global programs makes this GURU.Markets terminal chart clear: the quarterly EPS change and the -553.40 metric indicate the efficiency status of this innovative ecosystem.
Analytical breakdowns for MorphoSys Corporation (MOR)
- share price and expert price forecast:
- market capitalization details:
- book capitalization data:
- debt and liquidity details:
- earnings and market multiples details:
MOR - Company Net Income|Expected Profit MorphoSys AG|MOR - Business Payback Period|Projected Price to Earnings MorphoSys Corp|MOR - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple MorphoSys Corp|MOR - Operating profit EBITDA|Net earnings per share (EPS TTM) MorphoSys|MOR - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months morphosys.com|MOR - Net earnings per share growth this year|Net earnings per share growth forecast for next year MorphoSys AG
Summary company analytics:MorphoSys AG
Quarterly EPS growth measures the rate of change in net income per share compared to the same period last year, reflecting the efficiency of business scaling. By analyzing relative quarterly EPS dynamics, an investor assesses the fundamental momentum of MorphoSys AG, which, amid the Novartis acquisition, confirms the high scientific value of the oncology portfolio and the transparency of asset management.
Analysis of competing companies
ONC: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Halozyme Therapeutics, Inc. (HALO)|Year-over-year earnings per share growth for the last twelve months RevMed|Year-over-year net earnings per share growth for the last 12 months Ascentage Pharma Corp (AAPG)|Year-over-year earnings per share growth for the last twelve months CG Oncology, Inc. (CGON)|URGN - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Bicara Therapeutics BCAX|Year-over-year earnings per one share growth for the last 12 months PSNL|ERAS - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months DCTH|YMAB: Quarterly EPS earnings growth|aurabiosciences.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Candel Therapeutics Inc.|Earnings per share growth in annualized terms for the last twelve months Accuray Inc ARAY|Year-over-year earnings per share growth for the last twelve months SELLAS Life Sciences (SLS)|Year-over-year net earnings per share change for the last twelve months Actuate Therapeutics Inc|Citius Oncology, Inc. - Year-over-year net earnings per share growth for the last 12 months|TuHURA Biosciences Inc. (HURA) - Earnings per share growth in annualized terms for the last twelve months|TARA - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Fate Therapeutics Inc FATE|WHWK (aadibio.com) - Year-over-year net earnings per share growth for the last 12 months|TScan Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|CSBR (Champions Oncology Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth XBiotech USA|Quarterly EPS earnings growth CVM|OS Therapies Inc. (OSTX) - Net earnings per share growth for the trailing year|Year-over-year earnings per share growth for the last twelve months Radiopharm Theranostics RADX|ARTV - Year-over-year net earnings per share growth for the last 12 months|ANL - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months verupharma.com|Tempest Therapeutics, Inc. (TPST) - Year-over-year earnings per share growth for the last twelve months|Xilio Therapeutics - Year-over-year earnings per one share growth for the last 12 months|RENB (Renovaro Biosciences) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Mural Bio (MURA)|Quarterly EPS earnings growth KAPA|Quarterly EPS earnings growth onkuretherapeutics.com (OKUR)|Year-over-year earnings per share growth for the last twelve months CytoMed Therapeutics Limited GDTC|CRIS: Year-over-year earnings per share growth for the last 12 months|Apollomics Corp - Quarterly EPS earnings growth|Tharimmune Corporation (THAR) - Year-over-year net earnings per share growth for the last 12 months|ADVB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months genprex.com (GNPX)|Year-over-year earnings per share growth for the last twelve months Calidi Biotherapeutics Inc.|SBFM: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months XBIO (Xenetic Biosciences)|SLRX (Salarius Pharma) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PPBT (Purple Biotech)|AONC - Year-over-year net earnings per share growth for the last 12 months|BGNE: Year-over-year net earnings per share growth for the last 12 months|CKPT - Quarterly EPS earnings growth|Elevation Oncology (ELEV) - Year-over-year earnings per share growth for the last twelve months|iCAD - Year-over-year earnings per one share growth for the last 12 months|IKNA (Ikena Oncology Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months notablelabs.com NTBL|Year-over-year earnings per share growth for the last twelve months Viracta Therapeutics (VIRX)|Year-over-year net earnings per share growth for the last 12 months NAYA Biosciences Inc NAYA|Year-over-year earnings per share growth for the last twelve months Ascentage Pharma Group Ltd AAPGV
